The Handoff: Your Week in Rheumatology News – 12/2/16

–The long-term efficacy of several knee osteoarthritis (OA) treatments was recently examined in a network meta-analysis. It found no evidence of efficacy for nonsteroidal antiinflammatory drugs (NSAIDs), corticosteroids, acetaminophen, most bone acting agents, or slow-acting drugs compared with placebo, however found that glucosamine sulfate reduced radiologic joint space narrowing.

–A University of Birmingham study has ID’d the key roles that synovial fibroblast cells play in RA development, allowing for expanded research into effective and manageable treatments for the disease.

–Genalyte’s Maverick Detection System has demonstrated potential to improve testing turnaround time for the diagnosis of several conditions, including RA, according to pilot studies presented at the 2016 American College of Rheumatology (ACR) Annual Meeting.

–The US Preventive Services Task Force (USPSTF) gives a B grade recommendation to the use of low- and moderate-dose statin use in adults at risk for CVD.

–In a JAMA editorial, Andrew L. Beam, PhD, and Isaac S. Kohane, MD, PhD, of the department of Biomedical Informatics at Harvard Medical School, discuss the results of several recent studies focused on algorithms and artificial intelligence and how these breakthroughs may affect future clinical practice.

–Gail R. Wilensky, PhD, an economist and senior fellow at Project HOPE in Bethesda, MD, published a JAMA viewpoint article considering the future of the Affordable Care Act and the widespread impact of US health care policy.

–Two Stanford University cardiothoracic surgeons spoke with Rheumatology Advisor to offer their perspective on rheumatic heart disease and rheumatic carditis in the US.

–A randomized clinical trial published in JAMA Surgery last week investigated the role that decision aids play on access to total knee replacements in black patients with osteoarthritis.

–Even more reason to counsel your patients to put out those cigarettes: researchers at the Mayo Clinic have found that tobacco use negatively impacts flares and can affect remission in patients with RA.

–Nancy Lane, MD, director of the Center for Musculoskeletal Health at the University of California at Davis recently spoke with Rheumatology Advisor regarding expanded osteoporosis treatment options. View video below.

follow @RheumAdvisor